Foreword. The clinical aspects of deficit in dopaminergic ways.
Gessa
Gian Luigi
GL
B.B. Brodie Department of Neuroscience, University of Cagliari, Cagliari, Italy. lgessa@unica.it
Kasper
Siegfried
S
D000077582:Amisulpride; D000928:Antidepressive Agents / Q000627:therapeutic use; D017660:Autoreceptors / Q000037:antagonists & inhibitors / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism* / Q000523:psychology; D017448:Receptors, Dopamine D2 / Q000502:physiology; D050637:Receptors, Dopamine D3; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000928:Antidepressive Agents; D017660:Autoreceptors; C493593:DRD3 protein, human; D065127:Dopamine D2 Receptor Antagonists; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; D013469:Sulpiride; D000077582:Amisulpride; D004298:Dopamine